Nano-mupirocin: enabling the parenteral activity of mupirocin
Eur. J. Pharm. Sci. 2016, De Gruyter
Cern, A., Michael-Gayego, A., Bavli, Y., Koren, E., et al.
Cern, A., Michael-Gayego, A., Bavli, Y., Koren, E., et al.
Liposomal mupirocin holds promise for systemic treatment of invasive Staphylococcus aureus infections
J. Control. Release 2019, Elsevier
Goldmann, O., Cern, A., Müsken, M., Rohde, M., et al.
Goldmann, O., Cern, A., Müsken, M., Rohde, M., et al.
Therapeutic Potential of Injectable Nano-Mupirocin Liposomes for Infections Involving Multidrug- Resistant Bacteria
Pharmaceutics, 2021
Cern, A., Bavli, Y., Hod, A., Zilbersheid, D., Mushtaq, S., et al.
Cern, A., Bavli, Y., Hod, A., Zilbersheid, D., Mushtaq, S., et al.
New drug candidates for liposomal delivery identified by computer modeling of liposomes' remote loading and leakage
J. Control. Release 2017, Elsevier
Cern, A., Marcus, D., Tropsha, A., Barenholz, Y., et al.
Cern, A., Marcus, D., Tropsha, A., Barenholz, Y., et al.
In Vitro Susceptibility of Neisseria gonorrhoeae Strains to Mupirocin, an Antibiotic Reformulated...
Antimicrobial Agents & Chemotherapy, 2018
Ahuva Cern, Kristie L. Connolly, Ann E. Jerse, Yechezkel Barenholz
Ahuva Cern, Kristie L. Connolly, Ann E. Jerse, Yechezkel Barenholz
Effect of Solubilizing Agents on Mupirocin Loading into and Release from PEGylated Nanoliposomes
Journal of Pharmaceutical Sciences, 2014
Ahuva Cern, Einat Nativ-Roth, Amiram Goldblum, Yechezkel Barenholz
Ahuva Cern, Einat Nativ-Roth, Amiram Goldblum, Yechezkel Barenholz
